Insecticides (India) · NSE: INSECTICID · BSE: 532851

Q4 FY26 results · Jan–Mar 2026

Insecticides (India) reported revenue from operations of ₹426.26 crore (up 18.8% from Q4 FY25) and net profit of ₹11.71 crore (down 15.7% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations426.26358.92+18.8%384.92+10.7%
Other income4.732.86+65.7%0.76+520.6%
Total income430.99361.78+19.1%385.68+11.7%
Profit before share of associates & JVs and tax16.5722.02−24.8%14.06+17.9%
Share of profit/(loss) of associates & JVs(0.50)0.000.24
Net profit for the period11.7113.89−15.7%10.49+11.6%
EPS, basic (₹)4.024.77−15.7%3.60+11.7%
Net margin (%)2.73.92.7

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations427.96359.15+19.2%383.56+11.6%
Other income4.802.94+63.6%0.89+440.4%
Total income432.76362.08+19.5%384.45+12.6%
Profit before tax18.7022.25−15.9%12.23+52.9%
Net profit for the period14.3614.02+2.4%8.84+62.4%
EPS, basic (₹)4.944.82+2.5%3.04+62.5%
Net margin (%)3.43.92.3
Consolidated
Filed with BSE
28 May 2026, 17:12 IST
Board meeting
28 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
28 May 2026, 17:12 IST
Board meeting
28 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Audited
Source
XBRL filing on BSE